James E. Hosch
Director/Board Member at Arrogene, Inc.
James E. Hosch active positions
| Companies | Position | Start | End |
|---|---|---|---|
Arrogene, Inc.
 Arrogene, Inc. Pharmaceuticals: MajorHealth Technology Arrogene, Inc. commercializes a cancer treatment technology and a proprietary molecular delivery platform. Its technology delivers peptide, protein and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth or for imaging. The company was founded by Julia Ljubimova, Alexander Ljubimova, Keith Black and Eggehard Holler in 2006 and is headquartered in Los Angeles, CA. | Director/Board Member | 13/05/2016 | - |
Career history of James E. Hosch
Former positions of James E. Hosch
| Companies | Position | Start | End |
|---|---|---|---|
WestPark Capital, Inc.
 WestPark Capital, Inc. Investment ManagersFinance WestPark Capital, Inc. (WPC) is a SEC-registered investment advisor headquartered in Los Angeles, California. The firm was founded by Richard Rappaport in 1999 and is a subsidiary of Westpark Capital Group LLC. WPC offers investment services to individual and institutional investors. | Portfolio Manager-Equities | 30/03/2010 | - |
Training of James E. Hosch
| Texas A&M University | Undergraduate Degree |
Statistics
International
| United States | 4 |
Operational
| Portfolio Manager-Equities | 1 |
| Undergraduate Degree | 1 |
| Director/Board Member | 1 |
Sectoral
| Finance | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
WestPark Capital, Inc.
WestPark Capital, Inc. Investment ManagersFinance WestPark Capital, Inc. (WPC) is a SEC-registered investment advisor headquartered in Los Angeles, California. The firm was founded by Richard Rappaport in 1999 and is a subsidiary of Westpark Capital Group LLC. WPC offers investment services to individual and institutional investors. | Finance |
Arrogene, Inc.
Arrogene, Inc. Pharmaceuticals: MajorHealth Technology Arrogene, Inc. commercializes a cancer treatment technology and a proprietary molecular delivery platform. Its technology delivers peptide, protein and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth or for imaging. The company was founded by Julia Ljubimova, Alexander Ljubimova, Keith Black and Eggehard Holler in 2006 and is headquartered in Los Angeles, CA. | Health Technology |
- Stock Market
- Insiders
- James E. Hosch
- Experience
